InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Fonseca Lidia, 董事长兼首席执行官. Insider active across 3 companies, notably TEGNA INC. In total, 11 disclosures have been recorded. Activity tracked since 31 January 2022. The latest transaction was disclosed on 27 April 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Fonseca Lidia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
2,111 股0Ordinary SharesSEC:0001454944-26-000002:0
207 股@ US$81.900.0000% mcap3.0% 占其流量Ordinary SharesSEC:0001454944-26-000002:1
56,888 股@ US$33.8239.7% 占其流量Common StockSEC:0001225208-26-002817:0
2,083 股@ US$84.0433.1% 占其流量Ordinary SharesSEC:0001613103-25-000064:0
72,629 股@ US$31.3177.5% 占其流量Common StockSEC:0001225208-25-002704:0
162 股@ US$80.892.6% 占其流量Ordinary SharesSEC:0001613103-24-000048:0
2,165 股@ US$80.8635.3% 占其流量Ordinary SharesSEC:0001613103-24-000029:0
1,624 股@ US$90.6829.0% 占其流量Ordinary SharesSEC:0001613103-23-000026:0
6,039.39 股Common StockSEC:0001214659-23-006352:0
6,680 股@ US$52.690.0002% mcap50.0% 占其流量Common StockSEC:0001225208-22-001256:0
10,410 股Common StockSEC:0001214659-21-004902:0
11 条申报中的 11 条
About Fonseca Lidia
Lidia Fonseca is the CEO & Executive Vice President at TEGNA INC and Pfizer Inc. She oversees the strategic and business operations of both companies, focusing on innovation and growth. Her role is crucial for developing new initiatives and optimizing TEGNA and Pfizer's performance in their respective sectors.
